Finance

Lists
INCY:NASDAQ
Incyte Corp
127,81 US$
+0,46%
(+0,59) 1D
127,81 US$
0,00% (0,00)
After hours
Closed: 21 აგვ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INCY...
Open
126,45 US$
High
129,92 US$
Low
125,60 US$
Mkt. cap
25,91 მლრდ.
Avg. vol.
1,74 მლნ.
Volume
1,37 მლნ.
P/E ratio
16,29
52-wk high
132,58 US$
52-wk low
81,09 US$
EPS
7,85 US$
Beta
0,76
Shares outstanding
202,70 მლნ.
No. of employees
3 ათ.
Open
126,45 US$
High
129,92 US$
Low
125,60 US$
Mkt. cap
25,91 მლრდ.
Avg. vol.
1,74 მლნ.
Volume
1,37 მლნ.
P/E ratio
16,29
52-wk high
132,58 US$
52-wk low
81,09 US$
EPS
7,85 US$
Beta
0,76
Shares outstanding
202,70 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
https://www.dars.gov.et/
https://www.dars.gov.et/
·
1 თვის წინ
Incyte Q2 2026 Earnings: Key Factors to Watch - Tax Rate Impact
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEOHervé Hoppenot
Employees2,84 ათ.
Founded2002
Headquartersუილმინგტონი, დელავერის შტატი, ამერიკის შეერთებული შტატები
Sector-
Websiteincyte.com
Analyst ratings
Based on 21 analysts giving stock ratings to INCY in the past 3 months
Buy
Buy
11
Hold
10
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for INCY in the last 3 months.
Highest
Current 127,81 US$
155,00 US$ (+21,27%)
Average
130,79 US$ (+2,33%)
Lowest
104,00 US$ (-18,63%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Newman
Canaccord Genuity
Buy
Initiated
152,00 US$
+18,9%
08/21/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
150,00 US$
+17,4%
08/21/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/19/2026
Evan Seigerman
BMO Capital
Hold
Reiterated
130,00 US$
+1,7%
08/17/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
130,00 US$
+1,7%
08/17/2026
Jeffrey Walch
Bernstein
Hold
Reiterated
104,00 US$
-18,6%
08/12/2026
Derek Archila
Wells Fargo
Hold
Maintained
116,00 US$
-9,2%
08/06/2026
Salim Syed
Mizuho Securities
Buy
Maintained
137,00 US$
+7,2%
08/03/2026
Andrew Berens
Leerink Partners
Buy
Maintained
155,00 US$
+21,3%
08/03/2026
Jessica Fye
J.P. Morgan
Hold
Reiterated
120,00 US$
-6,1%
07/30/2026
Srikripa Devarakonda
Truist Financial
Hold
Reiterated
-
-
07/29/2026
Salveen Richter
Goldman Sachs
Hold
Maintained
118,00 US$
-7,7%
07/29/2026
Ashwani Verma
UBS
Hold
Maintained
113,00 US$
-11,6%
07/28/2026
Michael Schmidt
Guggenheim
Buy
Maintained
150,00 US$
+17,4%
07/28/2026
Brian Abrahams
RBC Capital
Hold
Maintained
109,00 US$
-14,7%
07/28/2026
Judah Frommer
Morgan Stanley
Hold
Maintained
119,00 US$
-6,9%
07/29/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
140,00 US$
+9,5%
07/28/2026
Etzer Darout
Barclays
Buy
Reiterated
139,00 US$
+8,8%
07/28/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
145,00 US$
+13,4%
07/28/2026
Jay Olson
Oppenheimer
Buy
Maintained
120,00 US$
-6,1%
07/28/2026
Marc Frahm
TD Cowen
Buy
Maintained
138,00 US$
+8%
07/28/2026
Unknown Analyst
Bernstein
Hold
Maintained
-
-
06/01/2026
Unknown Analyst
J.P. Morgan
Hold
Maintained
105,00 US$
-17,8%
05/20/2026
Unknown Analyst
Guggenheim
Buy
Maintained
130,00 US$
+1,7%
05/04/2026
Unknown Analyst
Argus Research
Buy
Maintained
115,00 US$
-10%
04/30/2026
Faisal Khurshid
Jefferies
Hold
Downgraded
94,00 US$
-26,5%
03/15/2026
Unknown Analyst
Evercore ISI
Hold
Maintained
110,00 US$
-13,9%
03/05/2026
Last report
28 ივლ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
3,09 US$ / 2,15 US$
+43,95%beat
Revenue / Est. (USD)
1,67 მლრდ. / 1,49 მლრდ.
+12,39%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,37 მლრდ.
1,51 მლრდ.
1,27 მლრდ.
1,67 მლრდ.
Cost of goods sold
605,58 მლნ.
732,55 მლნ.
620,43 მლნ.
621,91 მლნ.
Cost of revenue
605,58 მლნ.
732,55 მლნ.
620,43 მლნ.
621,91 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
328,29 მლნ.
388,96 მლნ.
327,06 მლნ.
350,72 მლნ.
Operating expense
328,29 მლნ.
388,96 მლნ.
327,06 მლნ.
350,72 მლნ.
Total operating expenses
933,87 მლნ.
1,12 მლრდ.
947,49 მლნ.
972,63 მლნ.
Operating income
432,11 მლნ.
385,32 მლნ.
325,19 მლნ.
701,41 მლნ.
Other non operating income
3,25 მლნ.
4,22 მლნ.
1,75 მლნ.
5,26 მლნ.
EBT including unusual items
482,31 მლნ.
389,94 მლნ.
343,60 მლნ.
751,51 მლნ.
EBT excluding unusual items
461,55 მლნ.
419,71 მლნ.
360,06 მლნ.
744,21 მლნ.
Income tax expense
58,14 მლნ.
90,66 მლნ.
40,27 მლნ.
165,91 მლნ.
Effective tax rate
12,05%
23,25%
11,72%
22,08%
Other operating expenses
-
-
-
-
Net income
424,17 მლნ.
299,28 მლნ.
303,33 მლნ.
585,60 მლნ.
Net profit margin
31,05%
19,86%
23,83%
34,98%
Earnings per share
2,26
1,80
1,81
3,09
Interest and investment income
26,78 მლნ.
30,75 მლნ.
33,69 მლნ.
38,12 მლნ.
Interest expense
-592,00 ათ.
-582,00 ათ.
-569,00 ათ.
-582,00 ათ.
Net interest expenses
26,19 მლნ.
30,17 მლნ.
33,12 მლნ.
37,54 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
456,13 მლნ.
409,30 მლნ.
348,99 მლნ.
727,89 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები